“Tumor ablation devices” offer several benefits over the traditional methods of treating cancer. In the coming years, the demand for these devices is therefore forecast to rise at an accelerated pace. In a report on “Global Tumor Ablation Devices Market, 2018-2025” Fortune Business Insights predicts a robust growth on cards owing to increasing incidence of cancer. Extensive use of these devices offers benefits such as faster recovery, minimal invasions, and less trauma. Furthermore, the rising geriatric population may facilitate the growth of the tumor ablation devices market in the coming years.
The report offers a comprehensive overview of the global market, compiling key insights into the prevailing trends. It profiles some of the leading players operating in the tumor ablation market, and gauges the impact of their key growth strategies. It studies the strengths and weaknesses of the companies profiled. Furthermore, using primary and secondary research methods the report identifies the growth opportunities and potential threats. It is therefore intended to offer an executive-level blueprint of the market to its stakeholders.
Technological advancements in tumor ablation devices and rising awareness about the same are likely to create lucrative prospects for the market’s growth. “Active presence of government and various healthcare agencies that help in creating awareness regarding various types of cancers will fuel the demand for tumor ablation devices,” says a lead analyst at FBI.
“Trailing North America, Asia Pacific and the Middle East & Africa are likely to emerge as lucrative markets for tumor ablation devices,” he further added. The rising prevalence of cancer is a primary factor driving the market in these regions. According to another survey conducted by the World Health Organization (WHO), in 2016 around 30 countries in Asia Pacific and Africa reported inadequate supply of tumor ablation devices. This in turn offers growth opportunities for the tumor ablation devices market.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Fortune Business Insights anticipates a positive growth trajectory for the global tumor ablation devices market. The market is driven by factors which include:
- Increasing Per Capita Income: Increasing per capita income especially in emerging regions may drive the market.
- Rising Disposable Income: Rapid rise in disposable income across various regions encourages people to opt for advanced therapies, hence supporting the market growth.
- MinimalTime: The time taken for treating cancerous tumor through tumor ablation devices is minimal. Additionally, this treatment involves minimum complications with enhanced efficacy.
- Increasing Availability: Increasing number of hospitals and rising awareness about cancerous tumor will subsequently increase the number of tumor ablation devices.
However, complex installation of these devices and lack of robust healthcare networks may restrain the market in some countries. Some leading companies such as Medtronic, Ethicon US, LLC., Sonacare Medical, Boston Scientific Corporation, AngioDynamics, and HealthTronics, Inc.